Rakovina Therapeutics Inc. (TSXV:RKV)
Canada
· Delayed Price · Currency is CAD 0.135
-0.005 (-3.57%)
At close: Mar 9, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 2.96 million as of March 9, 2026. Its market cap has decreased by -88.63% in one year.
Market Cap
2.96M
Enterprise Value
4.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 2.96M, a decrease of -80.10%. That is a compound annual growth rate of -27.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.96M | 40.00% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gemina Laboratories | 3.06M |
| Appili Therapeutics | 2.65M |
| ASEP Medical Holdings | 3.56M |
| MindBio Therapeutics | 3.84M |
| Algernon Health | 2.17M |
| XORTX Therapeutics | 4.18M |
| BioVaxys Technology | 4.41M |
| MYND Life Sciences | 5.22M |